ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,653.11
      0.39%
      US Tech 100
      19,823.60
      -0.11%
      Dow Jones
      40,799.99
      1.46%
      Brent Oil
      83.575
      -0.91%
      Bitcoin
      63,876.27
      -1.50%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Fulcrum Therapeutics Inc (FULC)

      7. Fulcrum Therapeutics Inc (FULC) Financials

      Fulcrum Therapeutics Inc

      Fulcrum Therapeutics Inc (FULC)

      NASDAQ
      9.02
      0.57
      ( 6.75% )
      Updated: 10:40:00
      Delayed by 15 minutes

      Fulcrum Therapeutics Inc Financial Summary

      The current FULC market cap is 560.63M. The company's latest EPS is USD -1.5660 and P/E is -5.89.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 685k295k1.18M871k0
      Operating Income -27.97M-27.94M-55.23M-27.99M-29.83M
      Net Income -26.14M-24.78M-48.56M-24.76M-26.87M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 08.82M19.16M6.34M2.81M
      Operating Income -84.22M-71.61M-81.05M-112.56M-110.66M
      Net Income -89.81M-70.82M-80.85M-109.87M-97.34M

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 226.69M321.12M300.33M257.69M232.59M
      Total Liabilities 27.74M24.86M24.9M22.5M19M
      Total Equity 198.94M296.26M275.43M235.19M213.59M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 110.44M129.58M235M226.69M257.69M
      Total Liabilities 23.29M34.4M23.46M27.74M22.5M
      Total Equity 87.15M95.18M211.54M198.94M235.19M

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -97.05M-24.12M-44.9M-90.97M-25.28M
      Investing 12.41M-93.94M-74.07M-36.69M38.13M
      Financing 84.32M117.69M117.84M118.12M1.65M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -39.48M-53.66M-78.48M-97.05M-90.97M
      Investing -944k-57.14M-129.67M12.41M-36.69M
      Financing 64.34M71.13M186.51M84.32M118.12M

      Stats and Ratios

      Market Cap 560.63M
      Price to Earnings Ratio -5.89
      Price to Sales Ratio 204.43
      Price to Cash Ratio 22.42
      Price to Book Ratio 2.44
      Dividend Yield -

      Share Statistics

      Shares Outstanding 62.15M
      Average Volume (1 week) 908.68k
      Average Volume (1 Month) 1.39M
      52 Week Change 143.78%
      52 Week High 13.70
      52 Week Low 3.14
      Spread (Intraday) 0.03 (0.33%)

      Company Info

      Company Name Fulcrum Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.fulcrumtx.com
      Industry pharmaceutical preparations (2834)